EVALUATION OF A MONOCLONAL ANTIBODY
$843,463N01FY2022AINIH
Dynport Vaccine Company, Llc, Frederick MD
Investigators
Abstract
The Biopharmaceutical Product Development Services program provides services to facilitate preclinical development of materials that are derived from biotechnology processes.
View original record on NIH RePORTER →